FAT1 and acute myeloid leukemia: This study also showed that FAT1 exerted tumour suppressor activity specifically in FLT3‐ITD‐positive AML, perhaps providing a partial explanation for the lack of prognostic impact of FLT3‐ITD in this subpopulation.